LAMEDITECH Co., Ltd. (KOSDAQ:462510)
South Korea · Delayed Price · Currency is KRW 6,870.00
-30.00 (-0.43%)
Dec 10, 2025, 3:30 PM KST
LAMEDITECH Revenue
LAMEDITECH had revenue of 1.76B KRW in the quarter ending September 30, 2025, with 3.83% growth. This brings the company's revenue in the last twelve months to 7.38B, up 33.74% year-over-year. In the year 2024, LAMEDITECH had annual revenue of 6.58B with 125.37% growth.
Revenue (ttm)
7.38B
Revenue Growth
+33.74%
P/S Ratio
8.20
Revenue / Employee
n/a
Employees
n/a
Market Cap
60.52B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.58B | 3.66B | 125.37% |
| Dec 31, 2023 | 2.92B | 862.48M | 41.95% |
| Dec 31, 2022 | 2.06B | 1.03B | 99.85% |
| Dec 31, 2021 | 1.03B | 824.53M | 403.91% |
| Dec 31, 2020 | 204.14M | -435.23M | -68.07% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5.50T |
| Celltrion | 3.90T |
| Yuhan | 2.14T |
| Hanmi Pharm. | 1.47T |
| SK Biopharmaceuticals | 675.41B |
| Sam Chun Dang Pharm. | 220.74B |
| ALTEOGEN | 202.18B |
| LigaChem Biosciences | 159.27B |